https://www.selleckchem.com/pr....oducts/CI-1040-(PD18
Under this condition, we substituted sorafenib of 400 mg/d for lenvatinib of 10 mg/d. After a 5-mo prescription, not only hypertension and peripheral edema were greatly improved, but also proteinuria was improved from grade three to grade one (estimated 24-h urine protein 962 mg). At the same time the cancer control was achieved, judged from computed tomography and laboratory evidence [thyroglobulin (Tg) before prescription of sorafenib 354.7 ng/mL; Tg after prescription of sorafenib 108.9 ng/mL]. Adaption from lenvatinib to
Like
Comment
Share
